Efaproxiral (BioDeep_00000178627)

   

human metabolite blood metabolite


代谢物信息卡片


2-(4-{[(3,5-dimethylphenyl)-C-hydroxycarbonimidoyl]methyl}phenoxy)-2-methylpropanoate

化学式: C20H23NO4 (341.16269980000004)
中文名称: 乙丙昔罗
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C
InChI: InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)

描述信息

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy
D006401 - Hematologic Agents > D000986 - Antisickling Agents
C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
D011838 - Radiation-Sensitizing Agents

同义名列表

12 个代谢物同义名

2-(4-{[(3,5-dimethylphenyl)-C-hydroxycarbonimidoyl]methyl}phenoxy)-2-methylpropanoate; 2-(4-(2-((3,5-Dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid; 2-(4-{[(3,5-dimethylphenyl)carbamoyl]methyl}phenoxy)-2-methylpropanoic acid; 2-{4-[(3,5-dimethylanilino)-carbonyl-methyl]-phenoxy}-2-methylpropionate; Efaproxiral; RSR13 CPD; 2-DACMPP; RSR 56; RSR-56; RSR 13; RSR-13; RSR13



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Guoyan G Xu, Tanvi M Deshpande, Mohini S Ghatge, Akul Y Mehta, Abdel Sattar M Omar, Mostafa H Ahmed, Jurgen Venitz, Osheiza Abdulmalik, Yan Zhang, Martin K Safo. Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry. Biochemistry. 2015 Dec; 54(49):7178-92. doi: 10.1021/acs.biochem.5b01074. [PMID: 26582149]
  • Rong Yi, Jasmeet Sandhu, Sarah Zhao, Geoffrey Lam, Devan Loganathan, Barbara Morrissey. Detection of efaproxiral (RSR13) and its metabolites in equine by liquid chromatography tandem mass spectrometry. Journal of mass spectrometry : JMS. 2014 Jan; 49(1):57-67. doi: 10.1002/jms.3304. [PMID: 24446264]
  • Giuseppe Lippi, Massimo Franchini, Gian Cesare Guidi. Blood doping by cobalt. Should we measure cobalt in athletes?. Journal of occupational medicine and toxicology (London, England). 2006 Jul; 1(?):18. doi: 10.1186/1745-6673-1-18. [PMID: 16863591]
  • Mario Thevis, Oliver Krug, Wilhelm Schänzer. Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry. Journal of mass spectrometry : JMS. 2006 Mar; 41(3):332-8. doi: 10.1002/jms.993. [PMID: 16421876]
  • T J Burke, D Malhotra, J I Shapiro. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model. Kidney international. 2001 Oct; 60(4):1407-14. doi: 10.1046/j.1523-1755.2001.00968.x. [PMID: 11576354]
  • B D Kavanagh, S R Khandelwal, R K Schmidt-Ullrich, J D Roberts, E G Shaw, A D Pearlman, J Venitz, K E Dusenbery, D J Abraham, M J Gerber. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. International journal of radiation oncology, biology, physics. 2001 Mar; 49(4):1133-9. doi: 10.1016/s0360-3016(00)01532-7. [PMID: 11240256]
  • J A Wahr, M Gerber, J Venitz, N Baliga. Allosteric modification of oxygen delivery by hemoglobin. Anesthesia and analgesia. 2001 Mar; 92(3):615-20. doi: 10.1097/00000539-200103000-00011. [PMID: 11226087]
  • A Breidbach, D H Catlin. RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry. Rapid communications in mass spectrometry : RCM. 2001; 15(24):2379-82. doi: 10.1002/rcm.523. [PMID: 11746905]
  • D J Abraham, F C Wireko, R S Randad, C Poyart, J Kister, B Bohn, J F Liard, M P Kunert. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry. 1992 Sep; 31(38):9141-9. doi: 10.1021/bi00153a005. [PMID: 1390701]